7-(4-Chlorobenzylidene)-3-[(4-chlorophenoxy)methyl]-6-(4-nitrothiophen-2-yl)-7H-1,2,4-triazolo[3,4-b][1,3,4]thiadiazine
暂无分享,去创建一个
[1] Anthony L. Spek,et al. Structure validation in chemical crystallography , 2009, Acta crystallographica. Section D, Biological crystallography.
[2] You‐Ming Zhang,et al. One-Pot Synthesis and Crystal Structure of 4-Phenyl-3-[4-chlorophenoloxymethyl]-1H-1,2,4-triazole-5(4H)-thione , 2007 .
[3] Mao‐Lin Hu,et al. Diethyl 3,8-dimethyl-4,7-diazadeca-2,8-dienedioate. , 2004, Acta crystallographica. Section C, Crystal structure communications.
[4] S. Verma,et al. Aromatase inhibitors in the adjuvant setting: bringing the gold to a standard? , 2004, Cancer treatment reviews.
[5] Shujuan Sun,et al. Liquid chromatography-tandem mass spectrometric method for the analysis of fluconazole and evaluation of the impact of phenolic compounds on the concentration of fluconazole in Candida albicans. , 2004, Journal of pharmaceutical and biomedical analysis.
[6] G. Johnston. Medicinal chemistry and molecular pharmacology of GABA(C) receptors. , 2002, Current topics in medicinal chemistry.
[7] D. Cremer,et al. General definition of ring puckering coordinates , 1975 .
[8] G. Sheldrick. A short history of SHELX. , 2008, Acta crystallographica. Section A, Foundations of crystallography.
[9] Olga Kennard,et al. Tables of bond lengths determined by X-ray and neutron diffraction. Part 1. Bond lengths in organic compounds , 1987 .